According to the report, the Asia-Pacific Cell Counting Market Size is valued at USD 0.18 billion in 2020 and projected to grow at a CAGR of 7.2%, to reach USD 0.26 billion by 2025 during the forecast period 2020-2025.
Cell counting is used to determine the number of live or dead cells concentration in the cell and also helps in the counting of blood cells in the samples. It is used in the medical diagnosis and treatment for the quantification of cells in the life sciences. It became an important subset of research areas like cancer biology, neurosciences, and immunology with various applications in the clinical practice. Generally, cell counts are expressed as a number of cells per unit of volume within the liquid media.
Cell counting products are being extensively used in pharmaceutical companies and research institutions with a rise in various chronic diseases such as cancer and AIDS. These products help the physician to understand why a patient feels unwell and what to do to help. Nowadays, this process has become an integral part of standard diagnosis in the clinics to determine the full blood count with the help of automated counters to find the concentration of RBCs, WBCs, platelets, and plasma. Cell counting is performed through several methods in which some are primitive and others require some special equipment.
The Asia-Pacific Cell Counting Market is driven by the factors like rising incidences of chronic diseases like cancer and AIDS, demand for cell counting products owing to the growing stem cell research and rise in next-generation technology products, growing awareness of the people in the healthcare sector, increased government policies and funding in the healthcare sector, new product innovations, rise in the advanced healthcare infrastructure and technology advancements in the existing products. However, high-cost equipment and a lack of proper research infrastructure are hampering the growth of the market.
Asia Pacific Cell Counting Market segmented and sub-segmented into the following categories.
On the basis of the product, the spectrophotometers segment accounted for the largest share of the market due to the enhanced data visualization and analysis software.
On the basis of region, the Asia-Pacific is anticipated to have the fastest growth rate owing to the rising population, investments in this area by the private companies, growing demographics, and the emerging economies.
Key Market Companies Operating the Asia Pacific Cell Counting Market are Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, Inc., GE Healthcare, Becton, Dickinson and Company, and PerkinElmer, Inc.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Instruments
5.1.2.1 Cell Counters
5.1.2.1.1 Automated Cell Counters
5.1.2.1.2 Hemocytometers and Manual Cell Counters
5.1.2.2 Hematology Analysers
5.1.2.3 Spectrophotometer
5.1.2.3.1 Single-Mode Readers
5.1.2.3.2 Multi-Mode Readers
5.1.2.4 Flow Cytometer
5.1.2.5 Hemocytometer
5.1.2.6 Others
5.1.3 Consumables
5.1.3.1 Microplates
5.1.3.2 Reagents
5.1.3.3 Assay Kits
5.1.3.4 Accessories
5.1.3.5 Others
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End-user
5.2.1 Introduction
5.2.2 Pharmaceutical & Biotechnology Industries
5.2.3 Hospitals & Diagnostic Laboratories
5.2.4 Research & Academic Institutes
5.2.5 Others
5.2.6 Y-o-Y Growth Analysis, By End-user
5.2.7 Market Attractiveness Analysis, By End-user
5.2.8 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End-user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End-user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of Asia Pacific
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific, Inc.,
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 Agilent Technologies
8.4 Bio-Rad Laboratories
8.5 Merck Millipore, Inc.,
8.6 GE Healthcare
8.7 Becton, Dickinson and Company
8.8 PerkinElmer, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
